Skip to main content
4SC AG logo

4SC AG — Investor Relations & Filings

Ticker · VSC ISIN · DE000A3E5C40 LEI · 391200QOKN7LGVP0RQ86 F Manufacturing
Open in API
Filings indexed 719 across all filing types
Latest filing 2007-04-26 Regulatory Filings
Country DE Germany
Listing F VSC

About 4SC AG

https://www.4sc.com/

4SC AG is a biopharmaceutical company that formerly focused on the research and development of small-molecule drugs for cancer treatment. The company's strategy centered on addressing diseases with high unmet medical needs by developing innovative therapies that targeted epigenetic mechanisms of action. According to the company's official statements, it currently has no products under development and no operational business.

Recent filings

Filing Released Lang Actions
4SC AG: 60 Patients in Phase IIa Clinical Trial
Regulatory Filings Classification · 90% confidence The document is a corporate press release announcing the progress of a clinical trial (Phase IIa) for a drug candidate (SC12267). It does not contain financial statements, dividend information, or regulatory filings, nor is it a report publication announcement. As it is a general corporate announcement regarding operational progress, it falls under the fallback category of Regulatory Filings (RNS). Q4 2007
2007-04-26 English
4SC AG: 60 Patienten in klinischer Phase IIa-Studie
Legal Proceedings Report Classification · 99% confidence The document is a press release dated April 26, 2007, from 4SC AG, providing an update on the progress of a clinical Phase IIa study for a drug candidate (SC12267) treating Rheumatoid Arthritis. It details patient recruitment status, study design, expected results timeline (Q4 2007), and background information on the disease and the company. This type of announcement, focusing on operational and clinical trial progress rather than comprehensive financial results (like a 10-K or IR) or management changes (MANG), fits best under the general category for corporate news updates that aren't strictly financial releases or regulatory filings. Since it is an update on a specific development stage, it is not a formal Earnings Release (ER) or Interim Report (IR). Given the options, this is a specific corporate update. It is not a formal regulatory filing like a 10-K, nor is it a presentation (IP) or a transcript (CT). It is a news announcement detailing operational progress, which often falls under general Regulatory Filings (RNS) if no better fit exists, or sometimes under Investor Presentation (IP) if it were structured as a presentation deck, but here it reads like a standard news release about R&D progress. However, since it is a specific operational update that is not a financial report, and it is not a proxy/voting document, dividend notice, or management change, the most appropriate category for specific, non-financial operational news that isn't a formal report announcement is often RNS, or potentially a specialized category if one existed. Given the provided definitions, this is a specific corporate update about R&D progress. It is not a formal financial report (10-K, IR), nor a management/board change (MANG), nor a dividend (DIV). It is a news item. RNS is the general regulatory filing fallback. Since it is a news release detailing clinical progress, it is best classified as a general Regulatory Filing (RNS) as it is an official communication to the market about company operations, or potentially a Legal/LTR if it were about a lawsuit, but it is not. I will classify it as RNS as the best fit for a non-standard, non-financial corporate announcement.
2007-04-26 German
Report Publication Announcement 2007
Report Publication Announcement Classification · 100% confidence The document is titled '4SC AG: Announcement according to articles 37v, 37w, 37x ff. WpHG' and specifically states '4SC AG: Preliminary announcement on the disclosure of financial statements'. It lists future dates for the disclosure of several reports: 'Financial report (half-year)' and 'Quarterly financial report'. Since the document's sole purpose is to announce *when* and *where* other reports will be published, it fits the definition of a Report Publication Announcement (RPA). The document length is short (1856 chars), supporting the 'MENU VS MEAL' rule.
2007-04-19 English
DGAP-DD: 4SC AG english
Director's Dealing Classification · 100% confidence The document explicitly uses the header "Directors’ Dealings" and details a transaction made by a person performing managerial responsibilities ("Member of a managing body"). The content describes the purchase of shares (Buy) by Ulrich Dauer, including the date, price, and number of items. This directly corresponds to the definition of Director's Dealing (insider trades).
2007-04-04 English
DGAP-DD: 4SC AG english
Director's Dealing Classification · 100% confidence The document explicitly uses the header "Directors’ Dealings" and details a transaction (Buy) made by a person performing managerial responsibilities (Daniel Vitt, Member of a managing body) in the company's shares. This directly corresponds to the definition of Director's Dealing, which is classified as code DIRS.
2007-04-04 English
DGAP-DD: 4SC AG english
Director's Dealing Classification · 100% confidence The document text explicitly contains the header "Directors’ Dealings" and details transactions made by a person performing managerial responsibilities ("Jörg Neermann, Function: Member of an administrative or supervisory body"). This directly corresponds to the definition of Director's Dealing reports, which are classified under the code DIRS.
2007-04-04 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.